AMIX Autonomix Medical, Inc.
$4.37▼ -0.34%
Healthcare
Other
After hours
$4.55▲ +4.12%
Sep 11, 7:53 PM ET
Volume 52.2K
Avg Volume (10D) 146.4K
Key Metrics & Fundamentals
Market Cap
$4.24M
P/E Ratio
–
Div Yield
–%
52W Range
2.44 - 32.55
% vs 50 MA
-26.68%
% vs 200 MA
-50.22%
RSI-14
41.9
MACD Histogram
-0.1200
Beta (1Y vs SPY)
5.37
Free Cash Flow
-$3.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.77M
COGS
–
Operating Exp
$2.77M
Operating Income
-$2.77M
EBIT
-$2.77M
Pretax Income
-$2.73M
Net Income
-$2.73M
EPS (Diluted)
-5.02
Price & Volume History
Loading chart…
Recent News
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
GlobeNewswire · Sep 1, 2026 12:30 PM
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
GlobeNewswire · Aug 26, 2026 12:30 PM
Top Midday Gainers
MT Newswires · Aug 25, 2026 5:16 PM
Autonomix Medical Shares Surge Pre-Bell After $4.9 Million Warrant Inducement Priced at Premium to Market
MT Newswires · Aug 25, 2026 9:35 AM
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
GlobeNewswire · Aug 25, 2026 1:06 AM
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
GlobeNewswire · Aug 12, 2026 12:15 PM
Top Premarket Decliners
MT Newswires · Aug 5, 2026 11:37 AM
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
InvestorsHub · Aug 4, 2026 3:24 PM
BC-Most Active Stocks
Associated Press · Aug 4, 2026 2:30 PM
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
GlobeNewswire · Aug 4, 2026 12:15 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AMIX's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.